PubMed دسترسی آزاد

Microneedle-Enabled Exosome Therapy: From Tumor Targeting to Precision Treatment of Complex Diseases.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Exosomes are nanoscale extracellular vesicles (EVs) that mediate intercellular communication by transporting proteins, lipids and nucleic acids. Their biocompatibility, low immunogenicity and intrinsic ability to protect labile cargo make them attractive therapeutic carriers. Yet their clinical translation remains constrained by heterogeneous isolation protocols, variable product purity, inefficient cargo loading, rapid systemic clearance and limited tissue-selective delivery. Engineering strategies, including parental-cell preconditioning, genetic modification, post-isolation cargo loading and surface functionalization, have improved the potency and targeting of exosome-based therapeutics but have not fully solved delivery-related bottlenecks. Microneedle (MN) systems provide a complementary solution by breaching the stratum corneum in a minimally invasive manner and depositing exosomes directly within defined tissue compartments. When integrated with dissolving, hydrogel, cryogenic, core-shell, Janus, threaded or stimulus-responsive MN architectures, exosomes can be retained locally, released in a programmed manner and protected from rapid degradation. This Review first summarizes the biological basis, source-dependent functions and engineering strategies of exosomes, and then outlines the design principles of MN platforms relevant to vesicle delivery. On this basis, we discuss representative studies in which MN systems have been explored to improve the local retention, controlled release and tissue-specific delivery of exosomes in cancer, wound repair, neurological injury, cardiovascular disease, immune-mediated disorders and other regenerative settings. We further summarize the translational barriers that remain for this emerging strategy, including vesicle characterization, potency assays, sterility control, scalable manufacturing, long-term safety, storage stability and batch-to-batch reproducibility.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

cancer immunotherapyexosomesextracellular vesiclesmicroneedlesregenerative medicinetransdermal delivery
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Decoding Nano-Bio Interactions: Gene Regulatory Networks in Advanced Drug Loading.

Conventional treatments often face challenges such as the limited ability to penetrate the blood-brain barrier (BBB). The Doxorubicin-loaded graphene oxide/magnetite (DOX/GO/Fe3O4) nanocomplex offers a promising platform due to GO's high surface area and pH-sensitive release, and Fe3O4's magnetic properties. This protocol describes the methodology for evaluating the cytotoxicity of free DOX versus the DOX/GO/Fe3O4 nanocomplex in the A-…

PubMed2026

Formulation, evaluation and characterization of fexofenadine IR and paracetamol SR multiparticulate drug delivery system.

BACKGROUND: Multiparticulate Drug Delivery (MDD) system are particularly considered as well suited systems for controlling oral preparations that have low risk of dose-dumping. OBJECTIVES: The current research work was aimed to prepare Fexofenadine HCl immediate release (IR) and Paracetamol sustained release (SR) pellets in a single dosage unit for the treatment of Allergic Rhinitis. Extrusion-spheronization was used to fabricate pelle…

PubMed2026

Improved transcutaneous delivery of cetirizine hydrochloride for the treatment of post-chemotherapy alopecia: Poke and emulgel approach.

BACKGROUND: Chemotherapy-induced alopecia negatively impacts the mental health of cancer patients. Topical minoxidil, a widely recommended drug for hair regrowth, causes scalp irritation and contact dermatitis. Oral minoxidil causes multiple cardiovascular and neurological side effects. Cetirizine hydrochloride, an antihistamine with a better safety profile than minoxidil, may stimulate hair follicle activity by modulating prostaglandi…